Precision targeting: The dawn of artificially customized disease resistance. [PDF]
PLoS PathogFan X, Lyu S, Fan W, Shu J, Cheng X.
europepmc +1 more source
Current Evidence on Voriconazole Exposure and Individualized Therapy for Aspergillosis. [PDF]
Infect Drug ResistWu Z, Lin Z, Jiang L.
europepmc +1 more source
Multitarget docking and molecular enumeration reveal DdpMPyPEPhU as a potent modulator of cell cycle, glucocorticoid, and estrogen signalling in breast cancer. [PDF]
PLoS OneAhmad S +5 more
europepmc +1 more source
Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy. [PDF]
Pharmaceuticals (Basel)Li X +6 more
europepmc +1 more source
Advancements in development of novel class of HIV protease inhibitors. [PDF]
Ann MedGu WG, Yin GZ, Zhang YP.
europepmc +1 more source
Insecticide Resistance Mutations, Enzymatic Activity, and Pathogen Infection in <i>Culex quinquefasciatus</i> from Haiti. [PDF]
InsectsTanachaiwiwat P +3 more
europepmc +1 more source
Enemy's arsenal backfires: pathogen proteases detonate broad-spectrum plant immunity via engineered NLRs. [PDF]
Stress BiolLiu S, Jing Y, Chen J.
europepmc +1 more source
Decoding efficacy and resistance space at a drug binding site. [PDF]
Nat CommunAltmann S +9 more
europepmc +1 more source
Leveraging conformational ensembles in allosteric drug discovery. [PDF]
Trends Pharmacol SciNussinov R, Regev C, Jang H.
europepmc +1 more source
Computational Identification of Potential Novel Allosteric IHF Inhibitors Using QSAR Modeling to Inhibit Plasmid-Mediated Antibiotic Resistance. [PDF]
Int J Mol SciSaurith-Coronell O +9 more
europepmc +1 more source